Pharmanutra S.p.A. (BIT: PHN) Stock Analysis & Fundamentals | ScreenerHero

Create free account

PHNPharmanutra S.p.A.

BIT · IT · Healthcare · Drug Manufacturers - Specialty & Generic · pharmanutra.it

87.70EUR0.00%Mkt Cap: 912.76M $P/E: 39.861d ago

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internati…

Industry Peers

Drug Manufacturers - Specialty & Generic

vs Drug Manufacturers - Specialty & Generic

P/E

Pricier

P/B

Pricier

Div Yield

Higher

1M Perf

Avg

$69.40BUSDP/E 25.2

United Therapeutics Corporation

$23.00BUSDP/E 20.0

Neurocrine Biosciences, Inc.

$16.95BUSDP/E 26.0

Swedish Orphan Biovitrum AB (publ)

$15.35BUSDP/E 175.0

$15.16BUSDP/E 31.8

Elanco Animal Health Incorporated

$8.30BUSDP/E 21.1

Hims & Hers Health, Inc.

Lantheus Holdings, Inc.

$7.22BUSDP/E 26.5

Liquidia Corporation

$7.09BUSDP/E 469.0

Amneal Pharmaceuticals, Inc.

$5.52BUSDP/E 46.8

Siegfried Holding AG

$3.54BUSDP/E 18.4

Hikma Pharmaceuticals PLC

$3.48BUSDP/E 11.1

Laboratorios Farmaceuticos Rovi, S.A.

$3.22BUSDP/E 22.4

$2.66BUSDP/E 59.3

Supernus Pharmaceuticals, Inc.

Dermapharm Holding SE

$2.54BUSDP/E 17.6

BioCryst Pharmaceuticals, Inc.

Prestige Consumer Healthcare Inc.

$2.24BUSDP/E 12.1

$1.92BUSDP/E 19.4

Amylyx Pharmaceuticals, Inc.

PolyPeptide Group AG

ANI Pharmaceuticals, Inc.

$1.88BUSDP/E 21.2

Bausch Health Companies Inc.

Faes Farma, S.A.

$1.56BUSDP/E 18.4

Xeris Biopharma Holdings, Inc.

$1.37BUSDP/E 113.1

Phibro Animal Health Corporation

$1.27BUSDP/E 13.5

BioGaia AB (publ)

$1.13BUSDP/E 35.6

Collegium Pharmaceutical, Inc.

$1.17BUSDP/E 17.6

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

BioAge Labs, Inc.

Cronos Group Inc.

$1.07BUSDP/E Infinity

Pacira BioSciences, Inc.

$998.26MUSDP/E 195.2

Eton Pharmaceuticals, Inc.

$895.85MUSDP/E 14.4

Amphastar Pharmaceuticals, Inc.

$889.80MUSDP/E 12.2

Esperion Therapeutics, Inc.

$814.31MUSDP/E Infinity

Ironwood Pharmaceuticals, Inc.

$693.02MUSDP/E 6.8

Knight Therapeutics Inc.

$704.28MUSDP/E 164.2

$522.76MUSDP/E 14.7

Aquestive Therapeutics, Inc.

Allergy Therapeutics plc

Canopy Growth Corporation

Emergent BioSolutions Inc.

Antibiotice S.A.

$317.55MUSDP/E 43.3

Organogenesis Holdings Inc.

Deva Holding A.S.

Akebia Therapeutics, Inc.

Alpha Teknova, Inc.

$288.10MUSDP/E 51.7

Cipher Pharmaceuticals Inc.

$308.25MUSDP/E 9.9

$294.94MUSDP/E 15.2

Celon Pharma S.A.

$268.98MUSDP/E 9.7

Animalcare Group plc

$250.67MUSDP/E 47.7

SIGA Technologies, Inc.

$261.08MUSDP/E 13.0

Laboratorio Reig Jofre, S.A.

$239.98MUSDP/E 53.8

Lifecore Biomedical, Inc.

Journey Medical Corporation

Anika Therapeutics, Inc.

Auxly Cannabis Group Inc.

$182.70MUSDP/E 8.8

Aurora Cannabis Inc.

$147.49MUSDP/E 18.8

Assertio Holdings Inc

Organigram Global Inc.

Cardiol Therapeutics Inc.

$119.66MUSDP/E 18.6

HLS Therapeutics Inc.

Cumberland Pharmaceuticals Inc.

Vistin Pharma ASA

$85.39MUSDP/E 12.3

Orexo AB (publ)

Shield Therapeutics plc

$66.94MUSDP/E 56.4

AB Science S.A.

Nanexa AB (publ)

ECO Animal Health Group plc

$66.36MUSDP/E 22.8

Enzymatica AB (publ)

Citius Oncology, Inc.

Cinclus Pharma Holding AB (publ)

Decibel Cannabis Company Inc.

Moberg Pharma AB (publ)

BioXcel Therapeutics, Inc.

Malin Corporation plc

$35.03MUSDP/E Infinity

Turk Ilac Ve Serum Sanayi Anonim Sirketi

TherapeuticsMD, Inc.

$25.58MUSDP/E 221.0

Aytu BioPharma, Inc.

Rubicon Organics Inc.

Rockwell Medical, Inc.

MediPharm Labs Corp.

Klaria Pharma Holding AB (publ.)

Voyageur Pharmaceuticals Ltd.

Medicon Hellas S.A.

$14.36MUSDP/E 17.5

Apimeds Pharmaceuticals US, Inc.

Biofrontera Inc.

Caring Brands, Inc.

PharmaCielo Ltd.

$7.07MUSDP/E 0.3

Sonoma Pharmaceuticals, Inc.

NUTEX Investments Public Limited Company

$4.95MUSDP/E 4.0

Mercanto Holdings Inc.

$5.64MUSDP/E Infinity

Eagle Pharmaceuticals, Inc.

$3.29MUSDP/E 1.4

Gabather AB (publ)

Enorama Pharma AB (publ)

Shuttle Pharmaceuticals Holdings, Inc.

$1.90MUSDP/E 32.5

CanadaBis Capital Inc.

Genix Pharmaceuticals Corporation

Petros Pharmaceuticals, Inc.

$216.1KUSDP/E 0.0

Clever Leaves Holdings Inc.

Indicators:|

Key Statistics

Company

Market Cap912.76M $

Enterprise Value904.36M $

Revenue (TTM)151.02M $

Gross Profit111.81M $

Net Income (TTM)21.74M $

Revenue/Share15.81 USD

Last Price87.70 EUR

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees140

CountryIT

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINIT0005274094

Valuation

P/E (Trailing)39.86

P/E (Forward)28.63

PEG—

EV/EBITDA25.04

EV/Revenue5.99

P/S6.04

P/B11.30

EPS (TTM)2.20

EPS (Forward)3.06

52W Range

38.7586% of range95.90

52W High95.90 EUR

52W Low38.75 EUR

Profitability

Gross Margin77.38%

Oper. Margin15.62%

EBITDA Margin23.92%

Profit Margin15.05%

ROE28.03%

ROA15.97%

Growth

Revenue Growth25.60%

Earnings Growth44.00%

Cash Flow & Leverage

Operating CF21.26M $

CapEx (TTM)3.41M $

FCF Margin10.55%

FCF Yield1.75%

Net Debt-10.77M $

Net Debt/EBITDA-0.30

Balance Sheet

Debt/Equity0.29

Current Ratio2.38

Quick Ratio1.84

Book Value/Sh7.758 EUR

Cash/Share3.021 EUR

Dividends

Fwd Div Rate1.200 EUR

Trail. Div Rate1.200 EUR

Div. Yield1.37%

5Y Avg Yield1.43%

Payout Ratio45.45%

Ex-Div DateMay 4, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)81.33 EUR

Upside (mean)-7.3%

Target Range76.00 EUR – 86.00 EUR

€76.00-7.3% to mean€86.00

# Analysts3

Ownership

Shares Out.9.58M

Float3.28M

Insiders65.02%

Institutions15.92%

Technical

SMA 5086.02 (+1.9%)

SMA 20065.65 (+33.6%)

Beta0.13

S&P 52W Chg20.05%

Avg Vol (30d)11.57K

Avg Vol (10d)9.99K

Technical Indicators

RSI (14)48.5

MACD0.3196

MACD Signal0.9881

MACD Hist.-0.6684

BB Upper93.75 EUR

BB Middle89.88 EUR

BB Lower86.00 EUR

BB Width8.63%

ATR (14)2.817 EUR

Vol Ratio (20d)0.27x